Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| MEIRAGTX | 12 | - | -1,86 % | ||
| TREVI THERAPEUTICS | 4 | - | 0,00 % | ||
| BIONTECH | 3 | 13 | +0,12 % | ||
| ALKERMES | 3 | 8 | -2,44 % | ||
| ALLOGENE THERAPEUTICS | 3 | 6 | +9,24 % | ||
| SPYRE THERAPEUTICS | 3 | 3 | 0,00 % | ||
| INSMED | 2 | 7 | +0,20 % | ||
| GILEAD SCIENCES | 2 | 5 | -0,29 % | ||
| ETON PHARMACEUTICALS | 2 | 5 | -9,46 % | ||
| VIR BIOTECHNOLOGY | 2 | 2 | -1,15 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05:18 | Trevi Therapeutics prices $150M stock offering at $13 per share | 4 | Investing.com | ||
| 04:48 | Trevi Therapeutics, Inc.: Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock | 1 | GlobeNewswire (USA) | ||
| 01:30 | BEONE MEDICINES (06160): DIRECTOR NOMINEES AND PROPOSED CHANGES IN BOARD COMMITTEE COMPOSITION | 1 | HKEx | ||
| Do | Altimmune-Aktionäre stimmen Verdopplung des genehmigten Aktienkapitals zu | 4 | Investing.com Deutsch | ||
| Do | Stifel initiates Definium stock with buy rating on anxiety drug | 3 | Investing.com | ||
| Do | Spyre Therapeutics closes $463.5M stock offering | 1 | Investing.com | ||
| Do | Autolus Therapeutics bestellt neuen Abschlussprüfer für das Geschäftsjahr 2026 | 8 | Investing.com Deutsch | ||
| Do | Spyre Therapeutics schließt Kapitalerhöhung über 463,5 Mio. US-Dollar ab | 2 | Investing.com Deutsch | ||
| Do | Is Vertex Pharmaceuticals' Empire in Trouble? | 5 | The Motley Fool | ||
| Do | Allogene raises $200.4 million in stock offering | 1 | Investing.com | ||
| Do | Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million | 1 | GlobeNewswire (USA) | ||
| Do | Janux doses first patient in JANX014 prostate cancer trial | 1 | Investing.com | ||
| Do | Trevi Therapeutics launches $150M public stock offering | 4 | Seeking Alpha | ||
| Do | Protagonist Therapeutics Reports Granting of Inducement Awards | 223 | ACCESS Newswire | NEWARK, CA / ACCESS Newswire / April 16, 2026 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on April 15, 2026, it issued inducement awards to two recently hired employees in accordance... ► Artikel lesen | |
| Do | PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 | 4 | GlobeNewswire (USA) | ||
| Do | Trevi Therapeutics, Inc.: Trevi Therapeutics Announces Proposed Public Offering of Common Stock | 1 | GlobeNewswire (USA) | ||
| Do | Altimmune, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Do | EyePoint, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Do | Allogene Therapeutics, Inc.: Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock | 1 | GlobeNewswire (USA) | ||
| Do | BAG schafft volle Transparenz: Moderna und Novavax: Bund zahlte eine Milliarde für Impfstoffe | 17 | Schweizer Fernsehen |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.